We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The MHRA and the Regulatory Innovation Office (RIO) invite organisations to share their views on the use of artificial intelligence (AI) in medicines development.
Proposals for ongoing cost-recovery and to fund higher value services.
The UK government response to the UK Covid-19 Inquiry Module 3 report on the impact of the pandemic on healthcare systems in the 4 nations of the UK.
Presented to Parliament by the Secretary of State for Health and Social…
Outlines the approach to assessing the objectives, rationale, costs and benefits of the proposed changes to section 75 of the NHS Act 2006.
Outlines the approach to assessing the objectives, rationale, costs and benefits of the proposed changes to patient safety measures as part of the Health Bill.
Outlines the approach to assessing the objectives, rationale, costs and benefits of the proposed changes to integrated care boards and foundation trusts as part of the Health Bill.
Outlines the approach to assessing the objectives, rationale, costs and benefits of the proposed changes to the medical device licensing regime as part of the Health Bill.
Outlines the approach to assessing the objectives, rationale, costs and benefits of the proposals to promote visiting as part of the Health Bill.
Outlines the approach to assessing the objectives, rationale, costs and benefits of the proposed changes to the pharmacy appeals process as part of the Health Bill.
Outlines the approach to assessing the objectives, rationale, costs and benefits of the Medicines and Healthcare products Regulatory Agency reforms as part of the Health Bill.
Outlines the approach to assessing equality impacts of the proposals to ensure that integrated care boards and local authorities consider visiting and involving other people in care decisions as part of the Health Bill.
Outlines the changes in the Health Bill relating to the legislation that governs medicines and medical devices.
Proposals for regulating tobacco, vaping and nicotine product packaging, device appearance and retail displays, to implement the Tobacco and Vapes Act.
Republished, closed consultation on plans to revise financial support for abattoirs and game handling establishments in England, Wales and Northern Ireland.
Memorandum on the European Convention on Human Rights (ECHR) relating to the Terminally Ill Adults (End of Life) Bill 2026.
The equality impact assessment considers the impacts of the Terminally Ill Adults (End of Life) Bill 2026.
The impact assessment considers the potential impacts of the Terminally Ill Adults (End of Life) Bill 2026.
This page provides a deposit for all materials published by the Government related to the Infected Blood Compensation Scheme.
Seeks views on a proposal to tighten controls on the substances Gamma-Butyrolactone (GBL) and 1,4-Butanediol (1,4-BD).
MHRA position paper, to help encourage the development and licensing of Microbiome-Based Medicinal Products (MBMPs) products in the UK.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).